This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schulz, E. Articles by Gilsanz, V. Search for Related Content PubMed PubMed Citation Articles by Schulz, E. Articles by Gilsanz, V.

Aortic Calcification and the Risk of Osteoporosis and Fractures

Department of Radiology, Loma Linda University Medical Center (E.S.), Loma Linda, California 92354; the Childrens Hospital Los Angeles, University of Southern California (K.A., X.L., V.G.), Los Angeles, California 90027; and the Department of Biostatistics, University of California Los Angeles (J.S.), Los Angeles, California 90024

Address all correspondence and requests for reprints to: Vicente Gilsanz, M.D., Ph.D., Department of Radiology, MS 81, 4650 Sunset Boulevard, Los Angeles, California 90027. E-mail: vgilsanz{at}chla.usc.edu.

We investigated the relation between computed tomography measures of aortic calcification and values for bone density and the number of fragility fractures in 2348 healthy, postmenopausal women. To determine whether increases in vascular calcification and bone loss progress in parallel, baseline values were compared with measurements obtained 9 months to 8 yr later in a subgroup of 228 women.

Of the 2348 subjects studied, 70% had osteoporosis, 30% had at least one vertebral fracture, and 9% had at least one hip fracture. Aortic calcifications were inversely related to bone density and directly related to fractures. After adjusting for age and potential confounders, measures for aortic calcification predicted 26.1% of the variance in bone density (P < 0.001). Compared with women without calcification, the odds ratios for vertebral and hip fractures in those with calcification were estimated to be 4.8 (95% confidence interval, 3.6–6.5) and 2.9 (95% confidence interval, 1.8–4.8), respectively. The subgroup analysis of 228 women longitudinally studied showed that the percentage of yearly increase in aortic calcification accounted for 47% of the variance in the percentage rate of bone loss (P < 0.001). Moreover, a strong graded association was observed between the progression of vascular calcification and bone loss for each quartile. Women in the highest quartile for gains in aortic calcification had four times greater yearly bone loss (5.3 vs.1.3% yearly; P < 0.001) than women of similar age in the lowest quartile. Smaller, but highly significant differences were also found between all other quartiles.

We conclude that aortic calcifications are a strong predictor for low bone density and fragility fractures.

This article has been cited by other articles:

				U. Sennerby, H. Melhus, R. Gedeborg, L. Byberg, H. Garmo, A. Ahlbom, N. L. Pedersen, and K. Michaelsson Cardiovascular Diseases and Risk of Hip Fracture JAMA, October 21, 2009; 302(15): 1666 - 1673. [Abstract] [Full Text] [PDF]

				M. Almeida, E. Ambrogini, L. Han, S. C. Manolagas, and R. L. Jilka Increased Lipid Oxidation Causes Oxidative Stress, Increased Peroxisome Proliferator-activated Receptor-{gamma} Expression, and Diminished Pro-osteogenic Wnt Signaling in the Skeleton J. Biol. Chem., October 2, 2009; 284(40): 27438 - 27448. [Abstract] [Full Text] [PDF]

				I. H. de Boer, B. Kestenbaum, A. B. Shoben, E. D. Michos, M. J. Sarnak, and D. S. Siscovick 25-Hydroxyvitamin D Levels Inversely Associate with Risk for Developing Coronary Artery Calcification J. Am. Soc. Nephrol., August 1, 2009; 20(8): 1805 - 1812. [Abstract] [Full Text] [PDF]

				T. C. Collins, S. K. Ewing, S. J. Diem, B. C. Taylor, E. S. Orwoll, S. R. Cummings, E. S. Strotmeyer, K. E. Ensrud, and for the Osteoporotic Fractures in Men (MrOS) Study Peripheral Arterial Disease Is Associated With Higher Rates of Hip Bone Loss and Increased Fracture Risk in Older Men Circulation, May 5, 2009; 119(17): 2305 - 2312. [Abstract] [Full Text] [PDF]

				T. Adragao, J. Herberth, M.-C. Monier-Faugere, A. J. Branscum, A. Ferreira, J. M. Frazao, J. Dias Curto, and H. H. Malluche Low Bone Volume--A Risk Factor for Coronary Calcifications in Hemodialysis Patients Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 450 - 455. [Abstract] [Full Text] [PDF]

				G. M. London Bone-Vascular Axis in Chronic Kidney Disease: A Reality? Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 254 - 257. [Full Text] [PDF]

				J. A. Hyder, M. A. Allison, N. Wong, A. Papa, T. F. Lang, C. Sirlin, S. M. Gapstur, P. Ouyang, J. J. Carr, and M. H. Criqui Association of Coronary Artery and Aortic Calcium With Lumbar Bone Density: The MESA Abdominal Aortic Calcium Study Am. J. Epidemiol., January 15, 2009; 169(2): 186 - 194. [Abstract] [Full Text] [PDF]

				M. Rodriguez-Garcia, C. Gomez-Alonso, M. Naves-Diaz, J. B. Diaz-Lopez, C. Diaz-Corte, J. B. Cannata-Andia, and the Asturias Study Group Vascular calcifications, vertebral fractures and mortality in haemodialysis patients Nephrol. Dial. Transplant., January 1, 2009; 24(1): 239 - 246. [Abstract] [Full Text] [PDF]

				N. D. Toussaint, K. K. Lau, B. J. Strauss, K. R. Polkinghorne, and P. G. Kerr Determination and Validation of Aortic Calcification Measurement from Lateral Bone Densitometry in Dialysis Patients Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 119 - 127. [Abstract] [Full Text] [PDF]

				N. D. Toussaint, G. J. Elder, and P. G. Kerr Bisphosphonates in Chronic Kidney Disease; Balancing Potential Benefits and Adverse Effects on Bone and Soft Tissue Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 221 - 233. [Abstract] [Full Text] [PDF]

				P. Muntner, T. M. Jones, A. D. Hyre, M. L. Melamed, A. Alper, P. Raggi, and M. B. Leonard Association of Serum Intact Parathyroid Hormone with Lower Estimated Glomerular Filtration Rate Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 186 - 194. [Abstract] [Full Text] [PDF]

				S. C. Manolagas De-fense! De-fense! De-fense: Scavenging H2O2 While Making Cholesterol Endocrinology, July 1, 2008; 149(7): 3264 - 3266. [Full Text] [PDF]

				A. Ishani, T. Blackwell, S. A. Jamal, S. R. Cummings, K. E. Ensrud, and for the MORE Investigators The Effect of Raloxifene Treatment in Postmenopausal Women with CKD J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1430 - 1438. [Full Text] [PDF]

				L. N. Bakhireva, G. A. Laughlin, R. Bettencourt, and E. Barrett-Connor Does Osteoprotegerin or Receptor Activator of Nuclear Factor-{kappa}B Ligand Mediate the Association between Bone and Coronary Artery Calcification? J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 2009 - 2012. [Abstract] [Full Text] [PDF]

				P. Raggi and M. Kleerekoper Contribution of Bone and Mineral Abnormalities to Cardiovascular Disease in Patients with Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 836 - 843. [Abstract] [Full Text] [PDF]

				A. E. Kearns, S. Khosla, and P. J. Kostenuik Receptor Activator of Nuclear Factor {kappa}B Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease Endocr. Rev., April 1, 2008; 29(2): 155 - 192. [Abstract] [Full Text] [PDF]

				J. Reddy, J. P. Bilezikian, S. J. Smith, and L. Mosca Reduced Bone Mineral Density Is Associated with Breast Arterial Calcification J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 208 - 211. [Abstract] [Full Text] [PDF]

				D. L. Andress Bone and Mineral Guidelines for Patients with Chronic Kidney Disease: A Call for Revision Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 179 - 183. [Abstract] [Full Text] [PDF]

				S. C. Manolagas and M. Almeida Gone with the Wnts: {beta}-Catenin, T-Cell Factor, Forkhead Box O, and Oxidative Stress in Age-Dependent Diseases of Bone, Lipid, and Glucose Metabolism Mol. Endocrinol., November 1, 2007; 21(11): 2605 - 2614. [Abstract] [Full Text] [PDF]

				M. Almeida, L. Han, M. Martin-Millan, L. I. Plotkin, S. A. Stewart, P. K. Roberson, S. Kousteni, C. A. O'Brien, T. Bellido, A. M. Parfitt, et al. Skeletal Involution by Age-associated Oxidative Stress and Its Acceleration by Loss of Sex Steroids J. Biol. Chem., September 14, 2007; 282(37): 27285 - 27297. [Abstract] [Full Text] [PDF]

				C. Vogelmeier and R. Bals Chronic Obstructive Pulmonary Disease and Premature Aging Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1217 - 1218. [Full Text] [PDF]

				R. Sabit, C. E. Bolton, P. H. Edwards, R. J. Pettit, W. D. Evans, C. M. McEniery, I. B. Wilkinson, J. R. Cockcroft, and D. J. Shale Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1259 - 1265. [Abstract] [Full Text] [PDF]

				W. Marz, U. Seelhorst, B. Wellnitz, B. Tiran, B. Obermayer-Pietsch, W. Renner, B. O. Boehm, E. Ritz, and M. M. Hoffmann Alanine to Serine Polymorphism at Position 986 of the Calcium-Sensing Receptor Associated with Coronary Heart Disease, Myocardial Infarction, All-Cause, and Cardiovascular Mortality J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2363 - 2369. [Abstract] [Full Text] [PDF]

				A. M. From, J. A. Hyder, A. E. Kearns, K. R. Bailey, and P. A. Pellikka Relationship Between Low Bone Mineral Density and Exercise-Induced Myocardial Ischemia Mayo Clin. Proc., June 1, 2007; 82(6): 679 - 685. [Abstract] [Full Text] [PDF]

				P. Raggi, A. Bellasi, E. Ferramosca, G. A. Block, and P. Muntner Pulse Wave Velocity Is Inversely Related to Vertebral Bone Density in Hemodialysis Patients Hypertension, June 1, 2007; 49(6): 1278 - 1284. [Abstract] [Full Text] [PDF]

				A. B. Lehtinen, K. P. Burdon, J. P. Lewis, C. D. Langefeld, J. T. Ziegler, S. S. Rich, T. C. Register, J. J. Carr, B. I. Freedman, and D. W. Bowden Association of {alpha}2-Heremans-Schmid Glycoprotein Polymorphisms with Subclinical Atherosclerosis J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 345 - 352. [Abstract] [Full Text] [PDF]

				M. C. Bezerra, G. D. Calomeni, V. F. Caparbo, E. S. Gebrim, M. S. Rocha, and R. M. R. Pereira Low bone density and low serum levels of soluble RANK ligand are associated with severe arterial calcification in patients with Takayasu arteritis Rheumatology, December 1, 2005; 44(12): 1503 - 1506. [Abstract] [Full Text] [PDF]

				H. C. W. Skinner Biominerals Mineralogical Magazine, October 1, 2005; 69(5): 621 - 641. [Abstract] [Full Text] [PDF]

				D. Hamerman Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies QJM, July 1, 2005; 98(7): 467 - 484. [Abstract] [Full Text] [PDF]

				A. A. Ali, R. S. Weinstein, S. A. Stewart, A. M. Parfitt, S. C. Manolagas, and R. L. Jilka Rosiglitazone Causes Bone Loss in Mice by Suppressing Osteoblast Differentiation and Bone Formation Endocrinology, March 1, 2005; 146(3): 1226 - 1235. [Abstract] [Full Text] [PDF]

				M. R. Rubin and S. J. Silverberg Vascular Calcification and Osteoporosis--The Nature of the Nexus J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4243 - 4245. [Full Text] [PDF]